<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Mospan, Geoffrey A.</style></author><author><style face="normal" font="default" size="100%">Wargo, Kurt A.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Researchers&#039; Experience with Clinical Data Sharing</style></title><secondary-title><style face="normal" font="default" size="100%">The Journal of the American Board of Family
                Medicine</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2016</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2016-11-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">805-807</style></pages><doi><style  face="normal" font="default" size="100%">10.3122/jabfm.2016.06.160198</style></doi><volume><style face="normal" font="default" size="100%">29</style></volume><issue><style face="normal" font="default" size="100%">6</style></issue><abstract><style  face="normal" font="default" size="100%">The topic of transparency in industry-sponsored clinical trials has gathered the attention of researchers in medicine. Patient-level data from recently completed clinical trials is now available for investigators to reanalyze or perform new analyses. In this Special Communication, the authors discuss their experience using this type of research and provide recommendations for success.</style></abstract></record></records></xml>